TWM631195U - Container structure for skin lightening care products - Google Patents
Container structure for skin lightening care products Download PDFInfo
- Publication number
- TWM631195U TWM631195U TW111204753U TW111204753U TWM631195U TW M631195 U TWM631195 U TW M631195U TW 111204753 U TW111204753 U TW 111204753U TW 111204753 U TW111204753 U TW 111204753U TW M631195 U TWM631195 U TW M631195U
- Authority
- TW
- Taiwan
- Prior art keywords
- acid
- container
- vitamin
- skin
- care products
- Prior art date
Links
Images
Landscapes
- Cosmetics (AREA)
- Table Devices Or Equipment (AREA)
Abstract
一種用於皮膚美白保養品容器結構,係包括一功效體、一容器及一蓋體,該功效體係容置填充於該容器內,該容器內部具有一容置空間連通一開口,該蓋體與該容器相對應組設,並該蓋體具有一結合部與所述開口相結合,其中該功效體係為一護膚品上或皮膚學上可接受之添加劑、一抗氧化劑、一發炎抑制劑、一黑色素生成抑制劑、一角質層代謝劑、一吸收促進劑所混合而成。A container structure for skin whitening and skin care products comprises a functional body, a container and a cover, the functional system is accommodated and filled in the container, the container has an accommodating space in communication with an opening, and the cover is connected to the container. The containers are arranged correspondingly, and the cover body has a joint part to be combined with the opening, wherein the efficacy system is a skin care product or a dermatologically acceptable additive, an antioxidant, an inflammation inhibitor, a It is a mixture of a melanin production inhibitor, a stratum corneum metabolizer, and an absorption enhancer.
Description
本創作係有關於一種護膚技術領域,尤指一種可有效減少黑色素產生藉以達到美白淡斑效果之用於皮膚美白保養品容器結構。The invention relates to the technical field of skin care, especially a container structure for skin whitening and skin care products that can effectively reduce the production of melanin to achieve the effect of whitening and lightening spots.
人體皮膚黑色素的形成起因於集中在表皮底層的黑色素細胞,當皮膚照射到紫外線,或是受到情緒、壓力或內分泌影響時,角質細胞會放出自由基,自由基是身體在維持生理機能中代謝產生的不穩定物質,它的活性極強,會主動與皮質中的物質行一系列氧化還原反應,進一步刺激末梢神經釋出介白素 (interleukin)、前列腺素(prostaglandin)等細胞激素,引起發炎反應,並促使腦下垂體分泌α黑色素細胞刺激素(α-melanocyte-stimulating hormon, α-MSH)。α-MSH會激活黑色素細胞內的酪胺酸酶活化,活化後的酪氨酸酶會與血液中的「酪氨酸」產生反應,經氧化作用而生成「多巴」經再次氧化後成為「多巴醌」,釋出黑色素與類黑色素;此時含有大量黑色素的黑色素體便藉由黑色素細胞的突觸把黑色素傳給周遭的角質細胞,以達到保護皮膚細胞的目的。接下來被釋放出的黑色素,會逐漸被送到表皮層,漸漸再移往表皮使皮膚變黑,最終被代謝掉。 因此,減少活性自由基刺激、抑制末梢神經作用,以及減緩介白素、前列腺素等造成的發炎反應或是抑制酪胺酸酶活性被視為減少黑色素產生(美白)的關鍵步驟。 是以,要如何解決上述習用之問題與缺失,即為從事此行業之相關廠商所亟欲研究改善之方向所在者。 The formation of human skin melanin originates from the melanocytes concentrated in the bottom layer of the epidermis. When the skin is exposed to ultraviolet rays, or is affected by emotions, stress or endocrine, the keratinocytes will release free radicals. Free radicals are produced by the body's metabolism in maintaining physiological functions. It is very active and will actively conduct a series of redox reactions with substances in the cortex, further stimulating peripheral nerves to release cytokines such as interleukin and prostaglandin, causing inflammation. And promote the pituitary gland to secrete α-melanocyte-stimulating hormone (α-melanocyte-stimulating hormon, α-MSH). α-MSH will activate the activation of tyrosinase in melanocytes, and the activated tyrosinase will react with "tyrosine" in the blood, and undergo oxidation to generate "dopa". Dopaquinone” releases melanin and melanoid; at this time, the melanosome containing a large amount of melanin transmits melanin to the surrounding keratinocytes through the synapses of melanocytes to achieve the purpose of protecting skin cells. The melanin that is released next will gradually be sent to the epidermis, and then gradually move to the epidermis to darken the skin, and finally be metabolized. Therefore, reducing active free radical stimulation, inhibiting peripheral nerve function, slowing down the inflammatory response caused by interleukins, prostaglandins, etc. or inhibiting tyrosinase activity are regarded as key steps to reduce melanin production (whitening). Therefore, how to solve the above-mentioned conventional problems and deficiencies is the direction that relevant manufacturers in this industry are eager to research and improve.
爰此,為有效解決上述之問題,本創作之主要目的在於提供一種具有美白淡斑效果之用於皮膚美白保養品容器結構。 本創作之次要目的,在於提供一種具有抗氧化效果之用於皮膚美白保養品容器結構。 本創作之次要目的,在於提供一種可有效減少黑色素產生之用於皮膚美白保養品容器結構。 為達上述目的,本創作係提供一種用於皮膚美白保養品容器結構,係包括一功效體、一容器及一蓋體,該功效體係容置填充於該容器內,該容器內部具有一容置空間連通一開口,該蓋體與該容器相對應組設,並該蓋體具有一結合部與所述開口相結合,其中該功效體係為一護膚品上或皮膚學上可接受之添加劑、一抗氧化劑、一發炎抑制劑、一黑色素生成抑制劑、一角質層代謝劑、一吸收促進劑所混合而成。 在一實施例中,所述功效體中的抗氧化劑包含至少二種抗氧化劑,該抗氧化劑係選自由以下所組成的群組:補骨脂酚(Bakuchiol)、維生素C(Vitamin C)、艾地苯(Idebenone)、輔酶Q10(coenzyme Q10)、維生素E(Vitamin E)、阿魏酸(ferulic acid)、白藜蘆醇(resveratrol)、麥角硫因(Ergothioneine)、鞣花酸(Ellagic acid)、穀胱甘肽(Glutathione)、壬二酸(Azelaic acid)、羥基苯氧基丙酸((R) -2- (4-hydroxyphenoxy) propionic acid [(R)-HPOPA])、光甘草啶(Glabridin)、四氫薑黃素(Tetrahydrocurcumin; THC),及其組合。 在一實施例中,所述功效體中的發炎抑制劑係選自由類固醇(steroid)、洋甘菊精(Chamomile Oil)、紅沒藥醇(Bisabolol)、維生素B5(Panthothenic Acid)其中任一或其組合,所述功效體中的黑色素生成抑制劑係選自由維生素B3(nicotinic acid)、羥基苯氧基丙酸((R) -2- (4-hydroxyphenoxy) propionic acid [(R)-HPOPA])其中任一或其組合,所述功效體中的角質層代謝劑係選自由維生素A((Vitamin A)、甘醇酸(Glycolic Acid)、乳酸(Lactic Acid )、水楊酸(Salicylic acid)、杏仁酸(Mandelic Acid)、壬二酸(Azelaic acid)、維生素B5(Panthothenic Acid)其中任一或其組合,所述功效體中的吸收促進劑係選自由乙醇(ethanol)、丙二醇(propylene glycol)、乙氧基乙二醇(ethoxydiglycol)、異山梨醇二甲基醚(Isosorbide Dimethyl Ether)、氮酮(Azone)其中任一或其組合。 在一實施例中,所述功效體中的護膚品上或皮膚學上可接受添加劑係選自由以下所組成的群組:水、甘油、蠟、醇類、植物油、礦物油、矽酮、脂肪酯、脂肪醇、乙二醇、聚乙二醇、及其組合。 在一實施例中,所述功效體之組成物係為:0.01至0.03重量百分比的麥角硫因、0.01至3重量百分比的四氫薑黃素、1至3重量百分比的維生素B3、1至3重量百分比的維生素B5及2至5重量百分比的乙氧基乙二醇。 在一實施例中,所述功效體可呈一凝膠、一乳劑、一水中油滴乳液、一油中水型乳液、一泡沫、一液體、一慕思、一粉末、一固體、或適合外部施加在人體皮膚的一軟膏狀。 在一實施例中,所述容器係可呈軟管式或罐裝式之結構態樣。 在一實施例中,所述容器之開口與蓋體之結合部彼此螺接。 透過本創作的各種具體實施例,本創作的有益效果為:本創作的功效體麥角硫因、四氫薑黃素、維生素B3、維生素B5及乙氧基乙二醇,具有協同增效的作用,製備得到的功效體具有較强的DPPH清除能力、總還原力、抑制發炎、抑制黑色素小體轉移、抑制酪胺酸酶活性,進以大幅減少黑色素產生,此外,該功效體含有具有加速角質層代謝功效並輔以皮膚角質層滲透功效之原料,如此可達到抗氧化美白的功效,能用於製備抗氧化美白護膚品。 Therefore, in order to effectively solve the above problems, the main purpose of this creation is to provide a container structure for skin whitening and skin care products with whitening and lightening effect. The secondary purpose of the present invention is to provide a container structure for skin whitening and skin care products with antioxidant effect. The secondary purpose of this creation is to provide a container structure for skin whitening skin care products that can effectively reduce the production of melanin. In order to achieve the above purpose, the present invention provides a container structure for skin whitening and skin care products, which includes a functional body, a container and a cover, the functional system is accommodated and filled in the container, and the container has a container inside. The space communicates with an opening, the cover body is correspondingly assembled with the container, and the cover body has a joint part to be combined with the opening, wherein the efficacy system is a skin care product or a dermatologically acceptable additive, a Antioxidant, an inflammation inhibitor, a melanin production inhibitor, a stratum corneum metabolizer, and an absorption enhancer are mixed together. In one embodiment, the antioxidants in the functional body include at least two antioxidants, and the antioxidants are selected from the group consisting of: Bakuchiol (Bakuchiol), Vitamin C (Vitamin C), Moxa Idebenone, coenzyme Q10, vitamin E, ferulic acid, resveratrol, ergothioneine, ellagic acid ), Glutathione, Azelaic acid, hydroxyphenoxypropionic acid ((R)-2- (4-hydroxyphenoxy) propionic acid [(R)-HPOPA]), licorice (Glabridin), tetrahydrocurcumin (Tetrahydrocurcumin; THC), and combinations thereof. In one embodiment, the inflammation inhibitor in the efficacy body is selected from any one of steroids (steroid), chamomile oil (Chamomile Oil), bisabolol (Bisabolol), vitamin B5 (Panthothenic Acid) or a combination thereof , the melanin production inhibitor in the functional body is selected from vitamin B3 (nicotinic acid), hydroxyphenoxy propionic acid ((R)-2-(4-hydroxyphenoxy) propionic acid [(R)-HPOPA]) wherein Any one or a combination thereof, the stratum corneum metabolizer in the functional body is selected from vitamin A (Vitamin A), glycolic acid (Glycolic Acid), lactic acid (Lactic Acid), salicylic acid (Salicylic acid), almond Acid (Mandelic Acid), Azelaic acid (Azelaic acid), vitamin B5 (Panthothenic Acid) any one or its combination, the absorption enhancer in the described efficacy body is selected from ethanol (ethanol), propylene glycol (propylene glycol), Any one of ethoxydiglycol, Isosorbide Dimethyl Ether, and Azone or a combination thereof. In one embodiment, the skincare or dermatologically acceptable additives in the efficacy body are selected from the group consisting of water, glycerin, wax, alcohol, vegetable oil, mineral oil, silicone, fat Esters, fatty alcohols, glycols, polyethylene glycols, and combinations thereof. In one embodiment, the composition of the functional body is: 0.01 to 0.03 weight percent of ergothioneine, 0.01 to 3 weight percent of tetrahydrocurcumin, 1 to 3 weight percent of vitamin B3, 1 to 3 Weight percent vitamin B5 and 2 to 5 weight percent ethoxyethylene glycol. In one embodiment, the functional body can be a gel, an emulsion, an oil-in-water emulsion, a water-in-oil emulsion, a foam, a liquid, a mousse, a powder, a solid, or a suitable An ointment for external application to human skin. In one embodiment, the container may be in the form of a hose or canned structure. In one embodiment, the opening of the container and the joint portion of the cover are screwed to each other. Through various specific embodiments of this creation, the beneficial effects of this creation are: the efficacy bodies of this creation, ergothioneine, tetrahydrocurcumin, vitamin B3, vitamin B5 and ethoxyethylene glycol, have a synergistic effect , the prepared efficacy body has strong DPPH scavenging ability, total reducing power, inhibition of inflammation, inhibition of melanosome transfer, inhibition of tyrosinase activity, thereby greatly reducing the production of melanin. Layer metabolism effect and supplemented by the skin stratum corneum penetration effect of raw materials, so it can achieve the effect of anti-oxidative whitening, can be used to prepare anti-oxidative whitening skin care products.
本創作之上述目的及其結構與功能上的特性,將依據所附圖式之較佳實施例予以說明。
在以下,針對本創作有關用於皮膚美白保養品容器結構之構成及技術內容等,列舉各種適用的實例並配合參照隨文所附圖式而加以詳細地説明;然而,本創作當然不是限定於所列舉之該等的實施例、圖式或詳細說明內容而已。
再者,熟悉此項技術之業者亦當明瞭:所列舉之實施例與所附之圖式僅提供參考與說明之用,並非用來對本創作加以限制者;能夠基於該等記載而容易實施之修飾或變更而完成之創作,亦皆視為不脫離本創作之精神與意旨的範圍內,當然該等創作亦均包括在本創作之申請專利範圍。
又,以下實施例所提到的方向用語,例如:「上」、「下」、「左」、「右」、「前」、「後」等,僅是參考附加圖示的方向。因此,使用的方向用語是用來說明,而並非用來限制本創作;再者,在下列各實施例中,相同或相似的元件將採用相同或相似的元件標號。
請參閱第1圖,係為本創作用於皮膚美白保養品容器結構第一實施例之結構示意圖,如圖所示,一種用於皮膚美白保養品容器結構1,係包括一功效體10、一容器11及一蓋體12,該功效體10係容置填充於該容器11的一容置空間110內,並該容器11一端具有一開口111與該容置空間110相連通,該蓋體12與該容器11相對應組設,當該蓋體12結合蓋設於該容器11上時,該開口111被該蓋體12封閉。
此外,為能提高重複使用性及保鮮性,於其中一實施例中,該蓋體12與該容器11係以螺接方式連結,具體來說,該容器11之開口111處外部設有複數外螺紋112(如第2圖所示),並該蓋體12之結合部120處對應地設有複數內螺紋,藉以達到容器11與蓋體12相互螺合連接。
為能因應不同行銷需求或增加攜帶便利性,該容器11係得以不同材質製備為不同型態,具體來說,該容器11可呈軟管式或罐裝式(如第2圖所示)之結構態樣。
前述之功效體10係為一護膚品上或皮膚學上可接受之添加劑、一抗氧化劑、一發炎抑制劑、一黑色素生成抑制劑、一角質層代謝劑、一吸收促進劑所混合而成。
所述功效體中的護膚品上或皮膚學上可接受之添加劑,包含但不限於:香料;防腐劑;醇類(如乙醇、丙醇和苯甲醇);甘油;粘合劑;流動劑;三乙酸甘油酯;植物油(如氫化植物油);礦物油;水;矽酮(如矽油);二氧化矽;蠟(如巴西棕櫚蠟和蜂蠟);脂肪酯和脂肪醇;乙二醇和聚乙二醇;及其組合。進一步說明,該功效體可包含一或多種額外的成分,合適的添加劑包含本創作中已知的那些添加劑,其包含但不限於保濕劑、潤膚劑、乳化劑、表面活性劑、油、抽出物、皮膚保護劑、消毒劑、防腐劑、抗神經痛化合物、抗氧化劑、去角質劑、香料、顏料、填充劑、溶劑、媒介物、載體、本技術具一般知識者已知的其他類型的添加劑、及其組合,這些添加劑可單獨使用或組合使用,具體而言,選擇性的添加劑可為用於個人護理產品和化妝品中的任何類型,皆包含在內。
所述功效體中的抗氧化劑用於指具有清除自由基之功能的化合物、植物抽出物或材料組合,其係包含選自以下二種所組成的群組:補骨脂酚(Bakuchiol)、維生素C(Vitamin C)、艾地苯(Idebenone)、輔酶Q10(coenzyme Q10)、維生素E(Vitamin E)、阿魏酸(ferulic acid)、白藜蘆醇(resveratrol)、麥角硫因(Ergothioneine)、鞣花酸(Ellagic acid)、穀胱甘肽(Glutathione)、壬二酸(Azelaic acid)、羥基苯氧基丙酸((R) -2- (4-hydroxyphenoxy) propionic acid [(R)-HPOPA])、光甘草啶(Glabridin)、四氫薑黃素(Tetrahydrocurcumin; THC),及其組合。
所述功效體中的發炎抑制劑係選自由類固醇(steroid)、洋甘菊精(Chamomile Oil)、紅沒藥醇(Bisabolol)、維生素B5(Panthothenic Acid)其中任一或其組合。
所述功效體中的黑色素生成抑制劑係選自由維生素B3(nicotinic acid)、羥基苯氧基丙酸((R) -2- (4-hydroxyphenoxy) propionic acid [(R)-HPOPA])其中任一或其組合。
所述功效體中的角質層代謝劑係選自由維生素A((Vitamin A)、甘醇酸(Glycolic Acid)、乳酸(Lactic Acid )、水楊酸(Salicylic acid)、杏仁酸(Mandelic Acid)、壬二酸(Azelaic acid)、維生素B5(Panthothenic Acid)其中任一或其組合。
所述功效體中的吸收促進劑係選自由乙醇(ethanol)、丙二醇(propylene glycol)、乙氧基乙二醇(ethoxydiglycol)、異山梨醇二甲基醚(Isosorbide Dimethyl Ether)、氮酮(Azone)其中任一或其組合。
在本創作的最佳實施例中,功效體之組成物係為:0.01至0.03重量百分比的麥角硫因、0.01至3重量百分比的四氫薑黃素、1至3重量百分比的維生素B3、1至3重量百分比的維生素B5及2至5重量百分比的乙氧基乙二醇,換句話說,於本創作中,最佳實施例的功效體具備了五種成分,並且每一成分分別具有不同的功效,此五種成分組成該功效體後而形成本創作之最佳實施態樣。
在各種具體實施例中,該功效體藉由外部施加在受試者的皮膚上,受試者通常為人,且可包含各種年齡層的男性和女性,需說明的是,本創作的方法/功效體不限於特定受試者。
該功效體可有各種形式,包含固體、凝膠和液體。舉例來說,可將功效體配製用以施用於受試者皮膚的凝膠、乳劑、乳液、軟膏、慕思、粉末或泡沫。在另一範例中,功效體可配製透過噴灑方式到受試者的皮膚上。此外,功效體也可配製成噴霧劑,如氣溶膠噴霧劑或泵式噴霧劑。在又一範例中,功效體還可配製供使用預濕紙巾來施用。在另一例子中,該功效體可配製成在受試者皮膚上磨擦的固體,類似於市面上之磨砂膏產品。
請參閱第3圖,為本創作形成該功效體的製備方法,首先,提供至少一護膚品上或皮膚學上可接受之添加劑,接著提供抗氧化劑、發炎抑制劑、黑色素生成抑制劑、角質層代謝劑及吸收促進劑共五種不同功效之原料,最後,將前述添加劑及各種原料按配比混合均勻,即得本創作之功效體。
需說明的是,若選擇所述抗氧化劑中的四氫薑黃素(Tetrahydrocurcumin; THC)當做該功效體的其中一種抗氧化劑的話,四氫薑黃素必須在所有原料混合後再將其加入。
接著,進一步說明本創作之功效體於製備供一受試者的皮膚美白之外用組合物的用途,該用途包含提供該外用組合物,並將該外用組合物施加至該受試者的皮膚上,更進一步說明,功效體可用以美白受試者的皮膚,如前所述,受試者通常為人,且可包含不同年齡的男性和女性,該功效體不限於特定的受試者或受試者上的皮膚位置。例如,個人可根據使用需求將組合物施用至其面部、頸部、手臂、手部、胸部、軀幹、腿部、腳部等或其任何組合,施用至皮膚的區域可能是色素過多或色素不足,例如,受試者的皮膚本身為黝黑、色素性皮膚變色、色素性胎記、色素過多、炎症後色素過多、損傷後色素過多、雀斑、老年斑、肝斑、太陽曬傷、曬黑、色素性痤瘡痕、疤痕、黑斑、黃褐斑、燒傷後疤痕、皮膚泛黃或黑眼圈等問題。
此外,該功效體可根據受試者的需求每天、一天數次施用,在本創作的方法中,施用(例如局部應用)的頻率可取決於若干因素,包含受試者期望的皮膚美白的程度。一般來說,使用頻率為每天一次或兩次施用功效體,使用時間包含早晨及/或晚上。
請參閱第4圖,為本發明組合物和習知成分(谷胱甘肽及輔酶Q10)相比較後的DPPH清除率結果統計圖,DPPH (1,1-diphenyl-2-picrylhydrazyl)是一種穩定的自由基,當其溶於甲醇或乙醇中會呈現藍紫色,當加入的成分樣品可以和 DPPH 自由基直接反應,則會阻斷 DPPH 自由基的連鎖反應,這時候呈現藍紫色的DPPH溶液顏色會轉成澄清的黃色,這就表示加入的成分樣品具有捕捉 DPPH自由基的能力,而呈現的顏色愈淡,則表示捕捉DPPH自由基的能力愈強,也就表示此成分樣品的抗氧化能力越好,因此,由圖可知,該組合物具有相當強的DPPH自由基的捕捉能力。
請參閱第5圖,為受試者持續使用該組合物後的美白效果統計圖,本實施例提供十位受試者使用該組合物,以一天使用兩次並持續56天後,利用肌膚檢測儀分別在受使者使用第0天及第56天時測量臉頰部位的美白效果,如圖顯示,明顯可知該組合物確實可達到美白的功效。
綜上所述,本創作相較於習知具有下列優點:
1.具有美白淡斑效果;
2.具有抗氧化效果;
3.有效減少黑色素產生。
以上已將本創作做一詳細說明,惟以上所述者,僅為本創作之一較佳實施例而已,當不能限定本創作實施之範圍。即凡依本創作申請範圍所作之均等變化與修飾等,皆應仍屬本創作之專利涵蓋範圍。
The above-mentioned purpose of the present invention and its structural and functional characteristics will be described with reference to the preferred embodiments of the accompanying drawings.
In the following, for the composition and technical content of the container structure for skin whitening and skin care products in this creation, various applicable examples are listed and described in detail with reference to the accompanying drawings; however, this creation is of course not limited to These examples, drawings or detailed descriptions are listed.
Furthermore, those who are familiar with this technology should also understand that: the enumerated embodiments and the attached drawings are only for reference and description, not for limiting the creation; it can be easily implemented based on these records. The creations completed by modification or alteration are also considered to be within the scope of the spirit and intent of this creation. Of course, such creations are also included in the scope of the patent application of this creation.
In addition, the directional terms mentioned in the following embodiments, such as "up", "down", "left", "right", "front", "rear", etc., are only for referring to the directions of the attached drawings. Therefore, the directional terms used are used to illustrate rather than limit the present invention; furthermore, in the following embodiments, the same or similar elements will use the same or similar reference numerals.
Please refer to FIG. 1 , which is a schematic structural diagram of the first embodiment of the container structure for skin whitening and skin care products according to the present invention. As shown in the figure, a
1:保養品容器結構 10:功效體 11:容器 110:容置空間 111:開口 112:外螺紋 12:蓋體 120:結合部 S1~S3:步驟 1: Container structure of skin care products 10: Efficacy body 11: Container 110: Accommodating space 111: Opening 112: External thread 12: Cover 120: Joint S1~S3: Steps
第1圖為本創作用於皮膚美白保養品容器結構第一實施例之結構示意圖; 第2圖為本創作用於皮膚美白保養品容器結構第二實施例之結構示意圖; 第3圖為本創作的功效體之製備步驟流程圖; 第4圖為本創作組合物和習知成分相比較後的DPPH清除率結果統計圖; 第5圖為受試者持續使用該組合物後的美白效果統計圖。 Figure 1 is a schematic structural diagram of the first embodiment of the container structure for skin whitening and skin care products created; Figure 2 is a schematic structural diagram of the second embodiment of the container structure for skin whitening and skin care products created; Figure 3 is a flow chart of the preparation steps of the functional body of this creation; Fig. 4 is a statistic diagram of the DPPH clearance rate result after comparing the composition with the conventional composition; Figure 5 is a statistical chart of the whitening effect after the subjects continued to use the composition.
1:保養品容器結構 1: Container structure of skin care products
10:功效體 10: Efficacy body
11:容器 11: Container
110:容置空間 110: Accommodating space
111:開口 111: Opening
12:蓋體 12: Cover
120:結合部 120: Joint
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111204753U TWM631195U (en) | 2022-05-09 | 2022-05-09 | Container structure for skin lightening care products |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW111204753U TWM631195U (en) | 2022-05-09 | 2022-05-09 | Container structure for skin lightening care products |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM631195U true TWM631195U (en) | 2022-08-21 |
Family
ID=83783413
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111204753U TWM631195U (en) | 2022-05-09 | 2022-05-09 | Container structure for skin lightening care products |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM631195U (en) |
-
2022
- 2022-05-09 TW TW111204753U patent/TWM631195U/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu | Natural products in cosmetics | |
KR20090130801A (en) | Composition for applying to skin externally containing extract from seeds of ginseng | |
KR20130088912A (en) | Skin external composition containing tangeretin and egcg | |
KR101382112B1 (en) | Composition of skin external application containing Chamaecyparis obtusa polysaccharide | |
KR101860109B1 (en) | Skin external composition containing floral ginsenoside | |
KR20160120355A (en) | Skin-brightening cosmetic composition | |
KR20130069512A (en) | Skin external composition comprising tangeretin | |
Lourith et al. | Formulation and clinical evaluation of the standardized Litchi chinensis extract for skin hyperpigmentation and aging treatments | |
WO2013030794A2 (en) | Use of substituted pyridines as skin depigmenting compounds | |
US11918666B2 (en) | Topical formulations comprising strontium and methylsulfonylmethane (MSM) and methods of treatment | |
KR20140120245A (en) | Composition for skin whitening containing corn silk extract | |
JP5010582B2 (en) | Depigmenting or glossy cosmetic composition comprising at least one oxazoline as an active ingredient | |
JP5138262B2 (en) | Topical skin preparation | |
TWM631195U (en) | Container structure for skin lightening care products | |
EP3463278B1 (en) | Use of thiophosphate derivatives as skin depigmenting agents | |
KR20120081788A (en) | A cosmetic composition containing acerola extract powder coated with silicone oil mixture | |
TW202344242A (en) | Compositions and related methods for skin lightening | |
KR20130115482A (en) | Skin external composition comprising germinated camellia sinensis seed extract | |
Ong et al. | 40 Skin whitening agents | |
KR100795515B1 (en) | Composition for skin whitening comprising artemisinine | |
Yadav et al. | A Review on:-Formulation and Development of Face wash | |
KR101877803B1 (en) | Skin external composition containing floral ginsenoside | |
KR101179308B1 (en) | Composition for skin-whitener containing saponified evening primrose seed oil as an effective ingredient | |
KR20180108253A (en) | Composition for skin improvement containing liquiritin apioside | |
KR102644106B1 (en) | Composition for skin improvement containing corytuberine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GD4K | Issue of patent certificate for granted utility model filed before june 30, 2004 |